Topics

pharmaceuticals

"A drug or medicine that is prepared or dispensed in pharmacies and used in medical treatment."  Compare with nutraceuticals.

Definition Source:  https://www.vocabulary.com/dictionary/pharmaceutical 

2015 Nobel Prize in Physiology or Medicine
A Combination of Ivermectin and Doxycycline Possibly Blocks the Viral Entry and Modulate the Innate Immune Response in COVID-19 Patients
A COVID-19 prophylaxis? Lower incidence associated with prophylactic administration of ivermectin
A living WHO guideline on drugs for covid-19
A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19
Amid Growing Evidence of Conflicts of Interest and Obdurate Groupthink in Medical Journals, Researchers Must Entertain Contrarian Ideas
An overview of the MATH+, I-MASK+ and I-RECOVER Protocols — A Guide to the Management of COVID-19
Anakinra for severe forms of COVID-19: a cohort study
Antiviral Effect of Budesonide against SARS-CoV-2
Antiviral effect of high-dose ivermectin in adults with COVID-19: A proof-of-concept randomized trial
Antiviral treatments [Molnupiravir] lead to the rapid accrual of hundreds of SARS-CoV-2 mutations in immunocompromised patients
Antiviral, virucidal and antioxidant properties of Artemisia annua against SARS-CoV-2
Bromhexine Hydrochloride Prophylaxis of COVID-19 for Medical Personnel: A Randomized Open-Label Study
Bromhexine Hydrochloride Tablets for the Treatment of Moderate COVID-19: An Open-Label Randomized Controlled Pilot Study
Bromhexine, for Post Exposure COVID-19 Prophylaxis: A Randomized, Double-Blind, Placebo Control Trial
Budesonide Works
Cardiac findings in a phase II double-blind randomized placebo-controlled trial of combination therapy (HAZDPac) to treat COVID-19 patients
Case report study of the first five COVID-19 patients treated with remdesivir in France
Changes in SpO2 on Room Air for 34 Severe COVID-19 Patients after Ivermectin-Based Combination Treatment: 62% Normalization within 24 Hours
Chloroquine is a potent inhibitor of SARS coronavirus infection and spread
Clinical outcomes after early ambulatory multidrug therapy for high-risk SARS-CoV-2 (COVID-19) infection
Coronavirus Disease 2019 (COVID-19) Treatment Guidelines
Coronavirus Disease 2019: Treatments Your Healthcare Provider Might Recommend for Severe Illness
Covid-19 Has Turned Public Health Into a Lethal, Patient-Killing Experimental Endeavor
COVID-19 outpatients: early risk-stratified treatment with zinc plus low-dose hydroxychloroquine and azithromycin: a retrospective case series study
COVID-19 Treatment Guidelines - Anti-SARS-CoV-2 Monoclonal Antibodies
COVID-19 Treatment Guidelines - Ivermectin
Covid-19: Should doctors recommend treatments and vaccines when full data are not publicly available?
Differential Effects of Antiseptic Mouth Rinses on SARS-CoV-2 Infectivity In Vitro
Does zinc supplementation enhance the clinical efficacy of chloroquine/hydroxychloroquine to win today's battle against COVID-19?
Down The Covid-19 Rabbit Hole: Independent Scientists And Physicians Unmask The Pandemic
Dr Mike Yeadon Ivermectin Anti-Fertility Bombshell: "One Of The Most Violent Fertility Toxins"
Drug Industry Documents
Early Ambulatory Multidrug Therapy Reduces Hospitalization and Death in High-Risk Patients with SARS-CoV-2 (COVID-19)
Early combination therapy with hydroxychloroquine and azithromycin reduces mortality in 10,429 COVID-19 outpatients
Effect of bromhexine on clinical outcomes and mortality in COVID-19 patients: A randomized clinical trial
Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trial
Evaluating the efficacy and safety of a novel prophylactic nasal spray in the prevention of SARS-CoV-2 infection: A multi-centre, double blind, placebo-controlled, randomised trial
Expedited COVID-19 vaccine trials: a rat-race with challenges and ethical issues
Exploring the binding efficacy of ivermectin against the key proteins of SARS-CoV-2 pathogenesis: an in silico approach
FDA Repays Industry by Rushing Risky Drugs to Market
FMTVDM Quantitative Nuclear Imaging finds Three Treatments for SARS-CoV-2
For “Such a Time as This”
HCQ for COVID-19: 412 studies from 8,590 scientists 529,060 patients in 58 countries
HCQ for COVID-19: real-time meta analysis of 368 studies
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
In Vitro Antiviral Activity of Doxycycline against SARS-CoV-2
Information for Clinicians on Investigational Therapeutics for Patients with COVID-19
Inhaled budesonide for COVID-19 in people at higher risk of adverse outcomes in the community: interim analyses from the PRINCIPLE trial
Insights from a computational analysis of the SARS-CoV-2 Omicron variant: Host-pathogen interaction, pathogenicity and possible therapeutics
1028